Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Clin Pharmacol. 2021 Jul 9;61(11):1421–1429. doi: 10.1002/jcph.1920

Table 1.

Adverse effects experienced by 6 patients with refractory chronic migraine who underwent 5-day continuous ketamine infusion.

Patient Day 1 Day 2 Day 3 Day 4 Day 5
A: 20 yo female, 64 kg Maximum ketamine rate (mg/h) 30 (0.5 mg/kg/h) 60 (0.9 mg/kg/h) 68 (1 mg/kg/h) 60 (0.9 mg/kg/h) 64 (1 mg/kg/h)
Adverse Effects None Nausea/vomiting Blurry vision; nausea/vomiting Blurry vision; hallucinations; nausea/vomiting Blurry vision; nausea/vomiting
B: 54 yo male, 84 kg Maximum ketamine rate (mg/h) 30 (0.4 mg/kg/h) 60 (0.7 mg/kg/h) 60 (0.7 mg/kg/h) 85 (1 mg/kg/h) 60 (0.7 mg/kg/h)
Adverse Effects None Blurry vision; hallucinations Blurry vision; hallucinations Blurry vision Blurry vision
C: 48 yo female, 83 kg Maximum ketamine rate (mg/h) 30 (0.4 mg/kg/h) 60 (0.7 mg/kg/h) 65 (0.8 mg/kg/h) 70 (0.8 mg/kg/h) 75 (0.9 mg/kg/h)
Adverse Effects None Blurry vision; nausea/vomiting Blurry vision; nausea/vomiting Blurry vision Blurry vision; nausea/vomiting
D: 28 yo male, 82 kg Maximum ketamine rate (mg/h) 30 (0.4 mg/kg/h) 40 (0.5 mg/kg/h) 50 (0.6 mg/kg/h) 55 (0.7 mg/kg/h) 50 (0.6 mg/kg/h)
Adverse Effects None Blurry vision; vivid dreams Blurry vision; vivid dreams Blurry vision; hallucinations; nightmares Blurry vision
E: 55 yo female, 69 kg Maximum ketamine rate (mg/h) 10 (0.1 mg/kg/h) 40 (0.6 mg/kg/h) 60 (0.9 mg/kg/h) 72 (1 mg/kg/h) 65 (0.9 mg/kg/h)
Adverse Effects None Nausea/vomiting None None Blurry vision; nausea/vomiting
F: 36 yo male, 94 kg Maximum ketamine rate (mg/h) 30 (0.3 mg/kg/h) 50 (0.5 mg/kg/h) 70 (0.7 mg/mg/h) 80 (0.9 mg/kg/h) 80 (0.9 mg/kg/h)
Adverse Effects None Blurry vision; nausea/vomiting Blurry vision; nausea/vomiting Blurry vision; nausea/vomiting Nausea/vomiting